Here’s what to know about Blujepa, the new FDA-approved UTI treatment heading to market this year
GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...
Endocrinology Advisor13h
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.
Everyday Health on MSN5d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...
Verywell Health on MSN1d
A New FDA-Approved Antibiotic May Help Women With Recurring UTIs
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
New Atlas2d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
FDA approves first new UTI drug in decades
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
Managed Healthcare Executive6d
FDA Approves UTI Antibiotic, Blujepa
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
clinicaladvisor.com6d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
“The approval of Blujepa is a crucial milestone with uUTIs among the most common infections in women,” said Tony Wood, Chief Scientific Officer, GSK. “We are proud to have developed ...
Can GSK's Blujepa provide relief from UTIs amid rising bacterial resistance and declining treatment efficacy?
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...